Cohance Lifesciences Ltd

NSE: COHANCE · BSE: 543064 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹455.00
Market cap: ₹17,408 Cr
Revenue (annual): ₹2,269 Cr
Net profit (annual): ₹179.2 Cr
P/E (TTM): 163.9×Sector 47.4×
Promoter holding: 57.49%+0.00% QoQ
FII holding: 6.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 4 Earnings Call 2 Annual General Meeting 2 Results Update 1 Results Correction 1 Merger & Restructuring 1 Financial Results 1 Employee Stock Options 1 Credit Rating 1 Capital Structure Change 1 Board Meeting Date 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

5 Aug 2026 18:06 IST NSE

Results Update

Cohance Lifesciences Results Update

Cohance Lifesciences reported Q1FY27 revenue from operations of ₹4,223 million, down 23.1% year-on-year. The company noted weak performance and expects improvement in the second half.

Read the filing ↗